Medasense


Medasense Biometrics Ltd. is a medical device company dedicated to transforming pain assessment and treatment worldwide through innovative AI technology and sensor platforms. Their flagship product, PMD-200™, visualizes pain response to personalize care, and their pipeline products focus on pain prediction, stratification, and prevention strategies. The company collaborates with industry leaders and is committed to improving patient outcomes and reducing healthcare costs by providing objective pain monitoring solutions.

Industries

Health Care
Artificial Intelligence
Medical Device
Sensor
Biometrics
Medical
Artificial Intelligence (AI)
Medical Equipment Manufacturing

Nr. of Employees

small (1-50)

Medasense


Patents

Device, system and method for perioperative pain management

US-12369851-B2

View Details

Device and method for determining spinal cord stimulation efficacy

US-12171571-B2

View Details

Systems and methods for monitoring physiological parameters during diathermy

US-12076155-B2

View Details

Electrode array for physiological monitoring and device including or utilizing same

US-11992303-B2

View Details

Device and method for determining spinal cord stimulation efficacy

US-11771369-B2

View Details

Electrode array for physiological monitoring and device including or utilizing same

US-11571137-B2

View Details
View All Patents

Products

Patient nociception monitoring system (bedside/OR monitor)

A bedside/operating-room patient monitor that integrates non-invasive biosensors and displays a computed nociception index to support intraoperative and critical-care analgesia management.

AI platform for pain prediction and stratification

Algorithmic platform and pipeline that extends real-time nociception monitoring toward pain prediction, patient stratification and prevention strategies.

NOL - Nociception Level Index

NOL (Nociception Level) is the technology and index developed by Medasense to objectively quantify a patient's physiological pain response (nociception), enabling clinical teams to provide personalized pain treatment.

PMD-200

A monitoring device leveraging NOL technology that quantifies the patient’s physiological response to pain (nociception) for operating room and critical care settings.

NOLedge

An agile physiological insights platform that transforms physiological data from multiple sources into pain-related insights for clinics and home care.


Services

Online and customized educational curricula, tutorials and training modules to support clinician competency and product evaluation.

Web-based simulation modules and interactive tools that let clinicians experience and practice use of nociception monitoring in simulated clinical scenarios.

On-site and remote clinical support for product evaluations, including training, reporting, and guidance to integrate monitoring into clinical workflows.

Expertise Areas

  • Nociception and perioperative pain monitoring
  • Clinical trial management and evidence generation
  • Medical device design and commercialization
  • Regulatory compliance and quality systems (medical devices)
  • Show More (4)

Key Technologies

  • Machine learning for biosignal analysis
  • Multi-parameter physiological signal fusion
  • Non-invasive biosensor integration
  • Bedside and operating-room patient monitoring hardware
  • Show More (2)

News & Updates

Medasense and Blink Device Company received a grant to develop an advanced anesthesia monitoring system.

Partnership to distribute NOL nociception monitoring technology in Israel.

NOL technology was featured in Nature Outlook highlighting its significance.

Medasense received patent approval for its novel pain-monitoring system.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.